Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV).
Transl Lung Cancer Res
; 12(1): 127-140, 2023 Jan 31.
Article
in En
| MEDLINE
| ID: mdl-36762057
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Transl Lung Cancer Res
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
China